Search

ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

SCImago Journal & Country Rank

2026, Vol 16, No. 2

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of integrative fields within Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Why Publish with APB?

Free of charge publication for all article types
Fast and constructive peer review
Simple and efficient online submission
Author-friendly review process
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Research Article

1. Bioinformatics and In Vitro Studies Reveal the Importance of p53, PPARG and Notch Signaling Pathway in Inhibition of Breast Cancer Stem Cells by Hesperetin

Adam Hermawan* , Muthi Ikawati, Annisa Khumaira, Herwandhani Putri, Riris Istighfari Jenie, Sonia Meta Angraini, Haruma Anggraini Muflikhasari

Adv Pharm Bull. 2021;11(2): 351-360. doi: 10.34172/apb.2021.033

PMCID: PMC8046396 PMID: 33880358 Scopus ID: 85103187034

Article

PDF

Suppl 1

Full Text

XML

Cited By:

7

7

3

Review Article

2. Advances in Targeted Therapies for Head and Neck Cancer Using Polymer-Based Nanoparticles

Mina Afrashteh Nour , Maryam Kouhsoltani* , Hamed Hamishehkar*

Adv Pharm Bull. 2026;16(2): 235-251. doi: 10.34172/apb.45968

Article

PDF

XML

Cited By:

Research Article

3. Two Simple Methods for Optimizing the Production of “Difficult-to-Express” GnRH-DFF40 Chimeric Protein

Mahdi Barazesh , Zohreh Mostafavipour , Soudabeh Kavousipour, Shiva Mohammadi , Pooneh Mokarram*

Adv Pharm Bull. 2019;9(3): 423-431. doi: 10.15171/apb.2019.050

PMCID: PMC6773931 PMID: 31592077 Scopus ID: 85070463403

Article

PDF

XML

Cited By:

3

1

3

Original Article

4. GAS2 Co-Expression Networks in Breast Cancer: Identification of Potential Biomarkers and Therapeutic Targets

Samin Rahimi , Mehdi Haghi* , Dariush Najarzadeh , Mohammad Ali Hosseinpour Feizi

Adv Pharm Bull. 2026;16(1): 129-138. doi: 10.34172/apb.025.46055

PMCID: PMC13408400 PMID: 42524055

Article

PDF

Full Text

XML

Cited By:

Editorial

5. Targeted Therapy Evolution from Defining a Sub-population to Crossing Multi-indications

Daohong Chen*

Adv Pharm Bull. 2024;14(4): 737-744. doi: 10.34172/apb.43306

PMCID: PMC11970494 PMID: 40190666

Article

PDF

Full Text

XML

Cited By:

0

Review Article

6. Nanotechnology-Based Drug Delivery for Parkinson’s Disease: A Review On Strategies, Efficacy and Translational Hurdles

Meghas Hari , Abhirami Subramony , Deepak Dwivedi , Reshmi S Krishnan, Aswin Damodaran, Sreeja C Nair*

Adv Pharm Bull. 2026;16(2): 252-267. doi: 10.34172/apb.46162

Article

PDF

XML

Cited By:

Review Article

7. The Challenges of Recombinant Endostatin in Clinical Application: Focus on the Different Expression Systems and Molecular Bioengineering

Abbas Mohajeri, Sarvin Sanaei, Farhad Kiafar, Amir Fattahi, Majid Khalili, Nosratollah Zarghami*

Adv Pharm Bull. 2017;7(1): 21-34. doi: 10.15171/apb.2017.004

PMCID: PMC5426730 PMID: 28507934 Scopus ID: 85017542839

Article

PDF

XML

Cited By:

14

10

16

Original Article

8. Design, Characterization, and In-Vitro Targeted Delivery of Melatonin via pH-Responsive Niosome Nanoparticles Decorated with Folate Against Colon Cancer Cells

Davoud Jafari-Gharabaghlou , Urjwan Alali, Fadhil Jawad Al-Tu’ma, Hamid Babavalian, Mozafar Mohammadi, Mohammad Sadegh Hashemzadeh*

Adv Pharm Bull. 2026;16(2): 377-386. doi: 10.34172/apb.46393

Article

PDF

XML

Cited By: